Dr. George Poste is Chief Scientist, Complex Adaptive Systems
Initiative (CASI) (http://www.casi.asu.edu/),
Regents’ Professor and Del E. Webb Chair in Health Innovation at
Arizona State University. He assumed this post in February
2009. This program links expertise across the university in
research on synthetic biology, ubiquitous sensing and healthcare
informatics for personalized medicine.
He founded the Biodesign Institute at ASU (www.biodesign.asu.edu/) and
served as Director for 2003 to 2009. In creating this Institute,
Dr. Poste designed and built 400,000 sq. ft. of new facilities,
achieved cumulative research funding of $300 million and recruited
over 60 faculty, including three members of the National Academies of
Science and Engineering.
He serves on the Board of
Directors of Monsanto (since 2003), Exelixis (since 2004), Caris Life Sciences (since 2005), and the
Scientific Advisory Board of Synthetic Genomics (since 2009). From 1992
to 1999 he was Chief Science and Technology Officer and President,
R&D of SmithKline Beecham (SB). During his tenure at SB he
was associated with the successful registration of 31 drug, vaccine
and diagnostic products. In
2004 he was named as ‘R&D Scientist of the Year’
by R&D Magazine, in 2006
he received the Einstein award from the Global Business
Leadership Council and in 2009 received the
Scrip Lifetime Achievement award voted by the leadership of the
global pharmaceutical industry.
He has published over 350 research papers and edited 14 books on
pharmaceutical technologies and oncology. He has received honorary
degrees in science, law and medicine for his research contributions
and was honored in 1999 by HM Queen Elizabeth II as a Commander of the
British Empire for his contributions to international healthcare and security.
He is a Fellow of the
Royal Society, the Royal
College of Pathologists and the UK Academy of Medicine, a
Distinguished Fellow at the Hoover Institution, Stanford University and a member of
the Council
for Foreign Relations. He served as a member of the
Defense Science Board from 2003 to 2009 and Health Board of the US
Department of Defense (DoD) and is currently a member of the US
Institute of Medicine Board on Global Health. He has
served as a member of Advisory Committees for multiple U.S. Government
Agencies in areas of defense, national security and healthcare.
